ELDN   $2.54  1.60% Market Closed After Close 2.53 -0.39%

Eledon Pharmaceuticals Inc
Total Cash 83.61M
totalCashPerShare 2.108
EBITDA
Total Debt 655.00K
quickRatio 13.877
currentRatio 14.477
Total Revenue
debtToEquity
Revenue/Share
ROA -0.25799
ROE -0.70711
grossProfits
freeCashflow -20.86M
operatingCashflow -37.90M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 22.13M
forwardPE -2.1875
floatShares 28.89M
sharesOutstanding 39.66M
sharesShort 117.87K
sharesShortPriorMonth 108.07K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.46%
Short Ratio help_outline 2.27%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue -0.221
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -32.33M
trailingEps 0.45%
forwardEps -1.20%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.26 3Q 2024
institutionsCount 38
lastUpdated Sept. 16, 2024, 8:10 p.m.